• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    IGC Pharma Engages Caregivers as CALMA Phase 2 Nears Completion

    PHARMIWEB

    IGC Pharma Enlists Tandem Clinical Research In CALMA Trial

    PHARMIWEB

    IGC Pharma To Present AI Platform For Alzheimer`s Data At ADPD

    ACCESSWIRE

    IGC Pharma Files Ai Patent For Alzheimer`s Research

    PHARMIWEB

    IGC Pharma Enrolls Visionary Investigators Network In CALMA

    PHARMIWEB

    IGC Pharma Protects IGC-AD1 in Phase 2 CALMA Trial

    PHARMIWEB

    IGC Pharma Raises Capital To Advance IGC-AD1 Phase 2 Trial

    PHARMIWEB

    IGC Pharma Obtains New US Patent For Pharmaceutical Cannabinoids

    PHARMIWEB

    IGC Pharma Benefits From Federal Shift To Schedule III

    PHARMIWEB

    Ascendiant Capital Raises IGC Pharma Price Target

    PHARMIWEB

    IGC Pharma Reaches 65% Enrollment Milestone In Alzheimer Trial

    PHARMIWEB

    USPTO Grants IGC Pharma Patent Covering IGC-AD1

    PHARMIWEB

    IGC Pharma To Host Fiscal 2026 Shareholder Update Call

    PHARMIWEB

    IGC Pharma Expands Ai-Powered Drug Discovery In-Silico Pipeline

    PHARMIWEB

    IGC Pharma Reaches Semi-Finals in Alzheimer’s AI Prize

    PR NEWSWIRE

    IGC Pharma Expands CALMA Trial To University Of South Florida

    ACCESSWIRE

    IGC Pharma Announces 2025 Stockholders Meeting Outcomes

    ACCESSWIRE

    IGC Pharma`s IGC-1C: Shows Promise In Disrupting Alzheimer

    ACCESSWIRE

    IGC Pharma Adds CALMA Ph 2 Alzheimer’s Trial Site

    ACCESSWIRE

    IGC Pharma Reports 50% Enrollment in Ph 2 CALMA Alzheimer`s Trial

    ACCESSWIRE

    IGC Pharma Gets Patent Nod for Microdose in Tourette`s Syndrome

    ACCESSWIRE

    IGC Pharma Expands CALMA Trial With Tekton Site in Oklahoma

    ACCESSWIRE

    IGC Pharma Expands CALMA Phase 2 Trial with Canadian Hamilton

    ACCESSWIRE

    IGC Pharma Update by AGP on Alzheimer`s Phase 2 CALMA Results

    ACCESSWIRE

    IGC Pharma Expands AI Platform for Alzheimer`s Detection

    ACCESSWIRE

    IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.